IL33 and COVID-19: It has been well documented that ESR and GLR are inflammatory markers associated with the pathogenesis of COVID-19 [26], and IL-22 and IL-33 may represent additional inflammatory markers associated with the development of mild/moderate SARS-CoV-2 infection.